Literature DB >> 23590739

State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose.

Andrea M Garcia1.   

Abstract

Today, opiate-based prescription painkillers account for significant morbidity and mortality in the U.S. According to the Centers for Disease Control and Prevention, prescription painkiller overdose has reached epidemic proportions over the past decade. This article explores the focus on inadequate treatment of pain in the U.S. and the subsequent rise of prescription painkiller abuse, misuse, and overdoses. Since 2007, states have increasingly used their authority to address inappropriate prescribing. State strategies to address this complex problem have included: establishing and strengthening prescription drug monitoring programs, regulating pain management facilities, and establishing dosage thresholds above which a consult with a pain specialist is required. With chronic pain affecting at least 116 million adults in the United States, it will also be important to evaluate the impact these policies are having on legitimate access to pain care.
© 2013 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23590739     DOI: 10.1111/jlme.12037

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  14 in total

1.  Opioid Prescriptions in Older Medicare Beneficiaries After the 2014 Federal Rescheduling of Hydrocodone Products.

Authors:  Yong-Fang Kuo; Mukaila A Raji; Victor Liaw; Jacques Baillargeon; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2018-04-14       Impact factor: 5.562

2.  The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.

Authors:  Chris Ringwalt; Mariana Garrettson; Apostolos Alexandridis
Journal:  J Prim Prev       Date:  2015-04

Review 3.  Current State of Opioid Therapy and Abuse.

Authors:  Laxmaiah Manchikanti; Adam M Kaye; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-05

4.  Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.

Authors:  Emma E McGinty; Mark C Bicket; Nicholas J Seewald; Elizabeth A Stuart; G Caleb Alexander; Colleen L Barry; Alexander D McCourt; Lainie Rutkow
Journal:  Ann Intern Med       Date:  2022-03-15       Impact factor: 51.598

5.  Murder Liability for Prescribing Opioids: A Way Forward?

Authors:  Y Tony Yang; Rebecca L Haffajee
Journal:  Mayo Clin Proc       Date:  2016-08-05       Impact factor: 7.616

6.  Seeking prescription opioids from physicians for nonmedical use among people who inject drugs in a Canadian setting.

Authors:  Mary Clare Kennedy; Thomas Kerr; Kora DeBeck; Huiru Dong; M-J Milloy; Evan Wood; Kanna Hayashi
Journal:  Am J Addict       Date:  2016-05-03

7.  State Medical Board Policy and Opioid Prescribing: A Controlled Interrupted Time Series.

Authors:  Shabbar I Ranapurwala; Christopher L Ringwalt; Brian W Pence; Sharon Schiro; Naoko Fulcher; Agnieszka McCort; Bethany L DiPrete; Stephen W Marshall
Journal:  Am J Prev Med       Date:  2020-12-10       Impact factor: 5.043

8.  Exploring perceptions and experiences of patients who have chronic pain as state prescription opioid policies change: a qualitative study in Indiana.

Authors:  Morhaf Al Achkar; Debra Revere; Barbara Dennis; Palmer MacKie; Sumedha Gupta; Shaun Grannis
Journal:  BMJ Open       Date:  2017-11-12       Impact factor: 2.692

9.  Dependence to legally prescribed opioid analgesics in a university hospital in Medellin-Colombia: an observational study.

Authors:  Maria G Garcia-Orjuela; Lineth Alarcon-Franco; Juan C Sanchez-Fernandez; Yuli Agudelo; Andres F Zuluaga
Journal:  BMC Pharmacol Toxicol       Date:  2016-09-14       Impact factor: 2.483

10.  Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014.

Authors:  Matthew E Hirschtritt; Kevin L Delucchi; Mark Olfson
Journal:  Prev Med Rep       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.